An anti-HIV microbicide engineered in commensal bacteria: Secretion of HIV-1 fusion inhibitors by lactobacilli

AIDS

Volumn 20, Issue 15, 2006, Pages 1917-1922

  Pusch, Oliver ^a   Kalyanaraman, Roopa ^b   Tucker, Lynne D ^c   Wells, Jerry M ^d   Ramratnam, Bharat ^c   Boden, Daniel ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anti HIV microbicide; Fusion inhibitors; HIV 1; Recombinant lactobacillus; Vaginal microbicide

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BETA GALACTOSIDASE; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ENVELOPE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS 1 FUSION INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS 1 FUSION INHIBITOR FI1; HUMAN IMMUNODEFICIENCY VIRUS 1 FUSION INHIBITOR FI2; HUMAN IMMUNODEFICIENCY VIRUS 1 FUSION INHIBITOR FI3; LUCIFERASE; MICROBICIDE; RECOMBINANT PROTEIN; SIGNAL PEPTIDE; SIGNAL PEPTIDE USP45; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG SPECIFICITY; GENETIC ENGINEERING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTOBACILLUS; LACTOBACILLUS GASSERI; LACTOBACILLUS PLANTARUM; LONG TERMINAL REPEAT; NONHUMAN; PHARMACEUTICAL ENGINEERING; PRIORITY JOURNAL; REPORTER GENE; SHUTTLE VECTOR; SIMIAN IMMUNODEFICIENCY VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS ISOLATION; VIRUS TRANSMISSION; VIRUS TYPING; WESTERN BLOTTING;

ANIMALS; ANTI-HIV AGENTS; BIOREACTORS; BLOTTING, WESTERN; HELA CELLS; HIV FUSION INHIBITORS; HIV INFECTIONS; HIV-1; HUMANS; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; NEUTRALIZATION TESTS; ORGANISMS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSDUCTION, GENETIC;

EID: 33748917747     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000247112.36091.f8     Document Type: Article

References (21)

1. Veazey RS, Klasse PJ, Schader SM, Hu Q, Ketas TJ, Lu M, et al. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 2005; 438:99-102.
2. Chang TL, Chang CH, Simpson DA, Xu Q, Martin PK, Lagenaur LA, et al. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc Natl Acad Sci USA 2003; 100:11672-11677.
3. Rao S, Hu S, McHugh L, Lueders K, Henry K, Zhao Q, et al. Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc Natl Acad Sci USA 2005; 102:11993-11998.
4. Pusch O, Boden D, Hannify S, Lee F, Tucker LD, Boyd MR, et al. Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin. J Acquir Immune Defic Syndr 2005; 40:512-520.
5. Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CC. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001; 33:894-896.
6. Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005; 191:25-32.
7. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-1868.
8. Chan DC, Kim PS. HIV entry and its inhibition. Cell 1998; 93:681-684.
9. Chan DC, Chutkowski CT, Kim PS. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc Natl Acad Sci USA 1998; 95:15613-15617.
10. Eron JJ, Gulick RM, Bartlett JA, Merigan T, Arduino R, Kilby JM, et al. Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV. J Infect Dis 2004; 189:1075-1083.
11. Wild CT, Shugars DC, Greenwell TK, McDanal CB, Matthews TJ. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci USA 1994; 91:9770-9774.
12. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289:1352-1355.
13. Robinson K, Chamberlain LM, Lopez MC, Rush CM, Marcotte H, Le Page RWF, et al. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect Immun 2004; 72:2753-2761.
14. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002; 46:1896-1905.
15. Derdeyn CA, Decker JM, Sfakianos JN, Zhang Z, O'Brien WA, Ratner L, et al. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol 2000; 74:8358-8367.
16. Hamburger AE, Kim S, Welch BD, Kay MS. Steric accessibility of the HIV-1 gp41 N-trimer region. J Biol Chem 2005; 280:12567-12572.
17. Tsai CC, Emau P, Jiang Y, Agy MB, Shattock RJ, Schmidt A, et al. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res Hum Retroviruses 2004; 20:11-18.
18. Lederman MM, Veazey RS, Offord R, Mosier DE, Dufour J, Mefford M, et al. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 2004; 306:485-487.
19. Harouse JM, Gettie A, Eshetu T, Tan RCH, Bohm R, Blanchard J, et al. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J Virol 2001; 75:1990-1995.
20. Ahrne S, Nobaek S, Jeppsson B, Adlerberth I, Wold AE, Molin G. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J Appl Microbiol 1998; 85:88-94.
21. Antonio MA, Hawes SE, Hillier SL. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999; 180:1950-1956.